Skip to main content

Fatblaster Clinical (Cancelled from the ARTG under 30(1)(g), 30(2)(aa) and 30(2)(ba), 30(2)(ea)(i) of the Act)

Product name
Fatblaster Clinical
ARTG
295575
Date action takes effect
Compliance action
Complementary medicine cancellation
Type of action
Cancelled from the ARTG under 30(1)(g), 30(2)(aa) and 30(2)(ba), 30(2)(ea)(i) of the Act
Grounds for regulatory action
The Secretary was satisfied that a statement made in, or in connection with, the application for listing of the goods was false or misleading in a material particular. It appeared to the Secretary that the presentation of the goods was unacceptable. As it appeared to the Secretary that the presentation of the goods was unacceptable, the certification made under s.26A(2)(c) of the Act was incorrect. The goods do not conform to a requirement relating to advertising applicable to the goods under Part 5-1 of the Act.

Help us improve the Therapeutic Goods Administration site